Literature DB >> 8695815

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

M Chesi1, P L Bergsagel, L A Brents, C M Smith, D S Gerhard, W M Kuehl.   

Abstract

Translocations involving the IgH locus at chromosomal locus 14q32.3 are a common event in many B-cell malignancies. The translocations, which generally occur into JH and switch regions, are mediated by errors in the two developmentally regulated, lymphocyte-specific pathways: VDJ-and switch-mediated recombination. Dysregulation of cyclin D1 by a t(11;14)(q13;q32) translocation occurs in most cases of mantle-cell lymphoma and in approximately 30% of multiple myeloma (MM) tumors in which a 14q32 translocation can be detected. We show here that in two of three myeloma lines that overexpress cyclin D1, there is an 11;14 translocation into a gamma switch region, suggesting an error in switch recombination. By contrast, 11;14 translocations in mantlecell lymphoma are invariably into or near a JH segment, suggesting an error in VDJ recombination. This is consistent with the fact that myeloma cells have undergone lgH switch recombination, whereas mantle-cell lymphoma cells generally have not.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8695815

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

Review 1.  The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Authors:  Sarah K Johnson; Christoph J Heuck; Anthony P Albino; Pingping Qu; Qing Zhang; Bart Barlogie; John D Shaughnessy
Journal:  Int J Hematol       Date:  2011-10-15       Impact factor: 2.490

2.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Authors:  M Chesi; E Nardini; L A Brents; E Schröck; T Ried; W M Kuehl; P L Bergsagel
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 3.  Genomics in multiple myeloma.

Authors:  Nikhil C Munshi; Hervé Avet-Loiseau
Journal:  Clin Cancer Res       Date:  2011-03-15       Impact factor: 12.531

Review 4.  Novel therapies in MM: from the aspect of preclinical studies.

Authors:  Teru Hideshima; Kenneth C Anderson
Journal:  Int J Hematol       Date:  2011-09-01       Impact factor: 2.490

Review 5.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

6.  Natural history of t(11;14) multiple myeloma.

Authors:  A Lakshman; M Alhaj Moustafa; S V Rajkumar; A Dispenzieri; M A Gertz; F K Buadi; M Q Lacy; D Dingli; A L Fonder; S R Hayman; M A Hobbs; W I Gonsalves; Y L Hwa; P Kapoor; N Leung; R S Go; Y Lin; T V Kourelis; J A Lust; S J Russell; S R Zeldenrust; R A Kyle; S K Kumar
Journal:  Leukemia       Date:  2017-06-27       Impact factor: 11.528

Review 7.  Reconstructing the evolutionary history of multiple myeloma.

Authors:  Francesco Maura; Even H Rustad; Eileen M Boyle; Gareth J Morgan
Journal:  Best Pract Res Clin Haematol       Date:  2020-01-11       Impact factor: 3.020

8.  Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.

Authors:  Fiona M Ross; Hervé Avet-Loiseau; Geneviève Ameye; Norma C Gutiérrez; Peter Liebisch; Sheila O'Connor; Klara Dalva; Sonia Fabris; Adele M Testi; Marie Jarosova; Clare Hodkinson; Anna Collin; Gitte Kerndrup; Petr Kuglik; Dariusz Ladon; Paolo Bernasconi; Brigitte Maes; Zuzana Zemanova; Kyra Michalova; Lucienne Michau; Kai Neben; N Emil U Hermansen; Katrina Rack; Alberto Rocci; Rebecca Protheroe; Laura Chiecchio; Hélène A Poirel; Pieter Sonneveld; Mette Nyegaard; Hans E Johnsen
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

Review 9.  Multistep tumorigenesis of multiple myeloma: its molecular delineation.

Authors:  Shinsuke Iida; Ryuzo Ueda
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

10.  Cyclin D1 expression in peripheral T-cell lymphomas.

Authors:  Joo Y Song; Liping Song; Alex F Herrera; Girish Venkataraman; Joyce L Murata-Collins; Victoria H Bedell; Yuan Yuan Chen; Young S Kim; Reda Tadros; Bharat N Nathwani; Dennis D Weisenburger; Andrew L Feldman
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.